日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Targeted Induction of Cancer Cell Necroptosis Potentiates Anti-PD-1 Immunotherapy via CD80 Activation.

靶向诱导癌细胞坏死性凋亡通过 CD80 激活增强抗 PD-1 免疫疗法。

Zhang Xu, Zhang Detian, Zhou Zhe, Liu Waner, Zhu Susi, Xiong Siyu, Chen Xiang, Peng Cong

Paradoxical Cutaneous Reaction: Secukinumab-Associated PLEVA in Palmoplantar Pustulosis

矛盾性皮肤反应:司库奇尤单抗相关性掌跖脓疱病中的PLEVA

Liu, Waner; Chen, Yuan; Lin, Zhimin; Zhang, Jianglin; Li, Chen

Co-assembled structures of Fe(3)O(4) nanoparticles for therapy of cervical cancer by inducing apoptosis and autophagy

通过诱导细胞凋亡和自噬治疗宫颈癌的Fe(3)O(4)纳米颗粒共组装结构

Dong, Sumiao; Liu, Waner; Yu, Dou; Zhang, Xian; Chen, Dailing; Wang, Ting

Ubiquitination in cancer: mechanisms and therapeutic opportunities

癌症中的泛素化:机制和治疗机遇

Zhu, Susi; Zhang, Xu; Liu, Waner; Zhou, Zhe; Xiong, Siyu; Li, Jie; Chen, Xiang; Peng, Cong

Crizotinib: A Novel Strategy to Reverse Immunosuppression in Melanoma by Targeting Lactate Transport.

克唑替尼:一种通过靶向乳酸转运逆转黑色素瘤免疫抑制的新策略

Zhou Zhe, Zhang Xu, Zhu Susi, Liu Waner, Guo Yeye, Xiong Siyu, Peng Cong, Chen Xiang

Fyn inhibition by TAE684: A synergistic strategy to suppress melanoma and reverse vemurafenib resistance.

TAE684 对 Fyn 的抑制:抑制黑色素瘤和逆转维莫非尼耐药性的协同策略。

Liu Waner, Zhang Xu, Liang Xiaowei, Guo Yeye, Zhou Zhe, Zhu Susi, Peng Cong, Chen Xiang

CEP192 is a novel prognostic marker and correlates with the immune microenvironment in hepatocellular carcinoma

CEP192 是一种新型预后标志物,与肝细胞癌的免疫微环境相关

Yanli Liu, Wanmei Liang, Yabin Chang, Zehui He, Meijian Wu, Haozhi Zheng, Xinrong Ke, Minjia Lv, Qingqian Liu, Qinyu Liu, Waner Tang, Qiaoling Huang, Yu Lu, Min He, Qijun Yang, Chunpan Mo, Jiefan Wang, Kunwei Peng, Zhiqun Min, Hang Su, Jingqi Chen